EUVIMEDEUVIMED entdecken
Crossref

Exploring the latency period in Chagas disease: duration and determinants in a cohort from Colombia

Mario Javier Olivera iD, Lyda Muñoz

Transactions of The Royal Society of Tropical Medicine and Hygiene · 2024

DOI: 10.1093/trstmh/trae004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transactions of The Royal Society of Tropical Medicine and Hygiene, 2024. Verfasst von Mario Javier Olivera und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de investigación en salud pública, Grupo de Parasitología, Instituto Nacional de Salud, Bogotá 111321, D.C., Colombia. Hauptthemen laut MEDLINE: Chagas Disease, Trypanosoma cruzi. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Instituto Nacional de Salud.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chagas disease has a varying latency period, the time between infection and onset of cardiac symptoms, due to multiple factors. This study seeks to identify and understand these factors to enhance our knowledge of the disease.

Methods

A retrospective follow-up study was conducted in Colombia on patients with indeterminate chronic Chagas disease. Medical files were examined to evaluate the disease latency time using time ratios (TRs) and the AFT Weibull model.

Results

The study followed 578 patients, of whom 309 (53.5%) developed cardiac disease, with a median latency period of 18.5 (95% CI 16 to 20) y for the cohort. Those with the TcISyl genotype (TR 0.72; 95% CI 0.61 to 0.80), individuals who lived 5–15 y (TR 0.80; 95% CI 0.67 to 0.95), 15–30 y (TR 0.63; 95% CI 0.53 to 0.74) or >30 y (vs 5 y) in areas with high disease prevalence had shorter latency periods. On the other hand, undergoing treatment increased the latency period (TR: 1.74; 95% CI 1.52 to 1.87).

Conclusions

The latency period of Chagas disease was found to be independently related to male gender, receipt of etiological treatment, length of time spent in an endemic area and the TcISyl genotype. The implications of these findings are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chagas DiseaseTrypanosoma cruziHumansColombiaMaleFemaleRetrospective StudiesAdultMiddle AgedFollow-Up StudiesGenotypeTime FactorsAdolescentRisk FactorsAgedYoung AdultPrevalenceChagas Cardiomyopathy

Stichwörter der Autor:innen

Trypanosoma cruziChagas cardiomyopathyChagas diseasedisease progressionlate onset disorders

Autor:innen und Institutionen

  • Departamento de investigación en salud pública, Grupo de Parasitología, Instituto Nacional de Salud, Bogotá 111321, D.C., Colombia.

ORCID-Profile: Mario Javier Olivera

Förderung

  • Instituto Nacional de Salud

Zitieren

APA

Olivera, M. J., & Muñoz, L. (2024). Exploring the latency period in Chagas disease: duration and determinants in a cohort from Colombia. Transactions of The Royal Society of Tropical Medicine and Hygiene. https://doi.org/10.1093/trstmh/trae004

Vancouver

Olivera MJ, Muñoz L. Exploring the latency period in Chagas disease: duration and determinants in a cohort from Colombia. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2024. doi:10.1093/trstmh/trae004

BibTeX
@article{Olivera2024,
  author = {Olivera, Mario Javier and Muñoz, Lyda},
  title = {Exploring the latency period in Chagas disease: duration and determinants in a cohort from Colombia},
  journal = {Transactions of The Royal Society of Tropical Medicine and Hygiene},
  year = {2024},
  doi = {10.1093/trstmh/trae004}
}
Kostenlos starten →